Nephrology Articles tagged as Randomized Trial

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB
N Engl J Med. 2005 Nov 24;353(21):2219-28
Google Plus
LinkedIn

Sequential therapies for proliferative lupus nephritis

Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D
N Engl J Med. 2004 Mar 4;350(10):971-80
Google Plus
LinkedIn

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group
N Engl J Med. 2003 Jul 3;349(1):36-44
Google Plus
LinkedIn

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group
N Engl J Med. 2003 Jul 3;349(1):36-44
Google Plus
LinkedIn

Effect of dialysis dose and membrane flux in maintenance hemodialysis

Eknoyan G1, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group
N Engl J Med. 2002 Dec 19;347(25):2010-9
Google Plus
LinkedIn

Effect of dialysis dose and membrane flux in maintenance hemodialysis

Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group
N Engl J Med. 2002 Dec 19;347(25):2010-9
Google Plus
LinkedIn

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA. 2002 Dec 18;288(23):2981-97
Google Plus
LinkedIn

Daily hemodialysis and the outcome of acute renal failure

Schiffl H, Lang SM, Fischer R
N Engl J Med. 2002 Jan 31;346(5):305-10
Google Plus
LinkedIn

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Edmund J. Lewis, M.D., Lawrence G. Hunsicker, M.D., William R. Clarke, Ph.D., Tomas Berl, M.D., Marc A. Pohl, M.D., Julia B. Lewis, M.D., Eberhard Ritz, M.D., Robert C. Atkins, M.D., Richard Rohde, B.S., and Itamar Raz, M.D., for the Collaborative Study G
N Engl J Med. 2001 Sep 20;345(12):851-60
Google Plus
LinkedIn

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, John
JAMA. 2001 Jun 6;285(21):2719-28
Google Plus
LinkedIn

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Frank M. Sacks, M.D., Laura P. Svetkey, M.D., William M. Vollmer, Ph.D., Lawrence J. Appel, M.D., George A. Bray, M.D., David Harsha, Ph.D., Eva Obarzanek, Ph.D., Paul R. Conlin, M.D., Edgar R. Miller, M.D., Ph.D., Denise G. Simons-Morton, M.D., Ph.D., Nj
N Engl J Med. 2001 Jan 4;344(1):3-10
Google Plus
LinkedIn

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN
N Engl J Med. 2000 Oct 19;343(16):1156-62
Google Plus
LinkedIn

Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G
N Engl J Med. 2000 Jan 20;342(3):145-53
Google Plus
LinkedIn

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA
N Engl J Med. 1998 Aug 27;339(9):584-90
Google Plus
LinkedIn

<<  1 2 3 [45  >>  
ukidneyisup